Schistosomiasis has a hugely detrimental effect on a child's mental and physical development. By treating children we are giving them the opportunity to reach their full potential and live healthier, happier lives.
As schistosomiasis poses a threat to people of all ages, unfortunate gaps exist in current treatment coverage and associated monitoring efforts, preventing subsequent health benefits to preschool-aged children as well as certain adolescents and adults. Current omission of these age groups from treatment and monitoring exacerbates health inequities and has long-term consequences for sustainable schistosomiasis control.
Derick Osakunor, from the University of Edinburgh, discusses the current treatment gaps in different age groups and how these are hindering the schistosomiasis goal of "elimination as a public health problem".
GSA 2019 report and 2020 operational strategy.
The GSA organised a COR NTD workshop on the Assessment of Schistosomiasis and Trachoma Distribution in Urban Areas for Targeted Intervention, on the 19th of November 2019.
March's edition of the Schisto Bulletin. News and updates from the schistosomiasis community.
End of Year letter from the GSA plus news and events from the Schistosomiasis Community.
October's edition of the Schisto Bulletin
July's edition of the Schisto Bulletin
In this special edition of the Schisto Bulletin GSA parnters and stakeholders from the schistosomiasis community share the impact of Covid-19 and associated restrictions on schistosomiasis community.
The GSA Executive Team is looking for individuals interested in becoming a GSA Ambassador in their country. The aim is to strengthen communication between the GSA and schistosomiasis programmes in endemic countries.